solifenacin succinate NDC 31722-027

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-027Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0027Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
31722-027-30	31722002730	30 TABLET, FILM COATED in 1 BOTTLE (31722-027-30)Marketed from Jun 15, 2022
31722-027-31	31722002731	10 BLISTER PACK in 1 CARTON (31722-027-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-027-32)Marketed from Jun 15, 2022
31722-027-90	31722002790	90 TABLET, FILM COATED in 1 BOTTLE (31722-027-90)Marketed from Jun 15, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): solifenacin succinate
Generic name (nonproprietary): solifenacin succinate
Active ingredients: Solifenacin succinate — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215761
Marketing start: Jun 15, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 31722-027_e52cdf06-9178-ab2f-e053-2a95a90af2b3SPL ID e52cdf06-9178-ab2f-e053-2a95a90af2b3SPL set ID 6479d24f-373e-4c9e-abaf-349f90a2bbb1RxCUI 477367, 477372UNII KKA5DLD701UPC 0331722028301, 0331722027908, 0331722027304, 0331722028905
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722002730 followed by a unit qualifier and the quantity

Package 31722-0027-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 1, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215761

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215761
Product	Strength	Form · route	Labeler	Product NDC
solifenacin succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-028